IMC Chicago’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
IMC Chicago's ARKG Position: Q4 2025 in Review
IMC Chicago sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 31,004 shares — an estimated $931K sold.
IMC Chicago first reported a position in ARKG in Q1 2021 and held it in 8 quarters. The position peaked at $1.96M in Q2 2025. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.
- IMC Chicago reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
- IMC Chicago sold 31,004 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $931K.
- IMC Chicago first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 8 quarters.
- IMC Chicago's ARK Genomic Revolution ETF position peaked at $1.96M in Q2 2025.
- 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.
Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.